Chief Financial Officer Jared Oasheim has announced his intention to resign from CVRx, Inc. to pursue other professional opportunities. He will remain in his role until a successor is appointed, with a full-time employment through at least August 31, 2026, or 30 days post-transition, followed by a consulting arrangement through February 2027 at $245 per hour. The company entered into an Employment Transition Agreement on June 8, 2026, which includes a $262,000 cash payment for transition assistance, eligibility for his 2026 cash incentive, and an extension of the post-termination exercise period for certain stock options. CVRx, Inc. is a medical device company focused on cardiovascular health technology.
